Syntheses of novel 3-amino-2(1H)-thioxo-4(3H)-quinazolinones and evaluation of their immunotropic activity. Part III

Archiv der Pharmazie

Volumn 330, Issue 12, 1997, Pages 399-405

  Nawrocka, Wanda ^a   Zimecki, Michał ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

6 oxo 1,4,5 thiadiazin 2,3 b quinazolinone; Immunotropic activity; Quinazoline derivatives

Indexed keywords

4 PHENYL 4 [2(1H) THIOXO 4(3H) OXOQUINAZOLIN 3 YLAMINO]BUTAN 2 ONE; CYCLOSPORIN A; LEVAMISOLE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMORAL IMMUNITY; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED CBA; QUINAZOLINES; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031468483     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.19973301208     Document Type: Article

References (22)

1. A.H. Amin, D.R. Mehta, S.S. Samarth, Fortschr. Arzneiminelforsch., 1970, 14, 218-262.
2. S. Johne, Pharmazie 1981, 36, 583-596.
3. N. Negwer, Organic-Chemical Drugs and Their Synonyms, Akademie-Verlag, Berlin, 1987.
4. The Merck Index, An Encyclopedia of Chemical Drugs and Biologicals, 12th ed. published by Merck and Co., Whitehouse Station NJ, USA, 1996.
5. J. Klinowska-Torz, Acta Polon. Pharm. 1994, 51, 249-250.
6. H. Shimura, R. Tarajima et al., Jpn. Kokai Tokkyo Koho, JP 0.7.101.941, 18 Apr 1995 [Chem. Abstr. 1995 123, 256753k]
7. A.J. Barker, F.T. Boyle, L.F.A. Heneguin, Brit. UK Pat. Appl., GrB 2.271.11.06, 1994 [Chem. Abstr. 1994 122, 160664k].
8. L. Korzycka, A. Szadowska. W. Pakulska, Pharmazie, 1994, 49, 815-819.
9. V.S. Pathak, I.S. Rathod, M.B. Patel, V.S. Shirsathm, K.S. Jain, Indian J. Chem. 1995, 34 B, 614-623.
10. W. Baker, L.A. Mitscher, PCT Int. Appl. WO 9513, 807, 1995 [Chem. Abstr. 1995 123, 256757g].
11. W. Nawrocka, J.J. Staśko, Boll. Chim. Farmacentica 1997, 136 in press.
12. W. Nawroka, B. Sztuba, Polish J. Chem. 1996, 70, 197-201.
13. W. Nawrocka, J.J. Staśko, Polish J. Chem. 1997, 71, 792-796.
14. G. Nadler, I. Delimage, P. Lahouratate, I. Leger, M. Morvan, R.G. Zimmermann, Eur. J. Med. Chem. 1996, 31, 805-812.
15. N. Ergene, N. Ulusoy, G. Capan, G.O. Sanis, M. Kiraz, Arch. Pharm. Pharm. Med. Chem. 1996, 329, 427-430.
16. R. Fioravatani, M. Biava, S. Donnarumma, G.S. Poretta, Il Farmaco 1996, 51, 643-652.
17. E. Sadova, V. Ciganekova, Czech. C. S. 276, 501 [Chem. Abstr. 1994 120, 27038f].
18. E. Sadova, V. Ciganekova, Czech. C. S. 276, 501 [Chem. Abstr. 1994 120, 27038f].
19. J. Klinowska-Torz, D. Skwarski, S. Sobiak, S. Piechocki. Polish J. Chem. 1997, 71, 57-62.
20. A. Yesilada, E. Zorku, F. Aksu, E. Yesilada, Il Farmaco 1996, 51, 595-599.
21. R.J Mishell, R.W. Dutton. J. Exp. Med. 1967, 126, 423-428.
22. P.H. Lagrange, G.B. Mackeness, T.E. Miller, P. Pardon, J. Exp. Med. 1974, 139, 528-542.